Interestingly, c-MYC itself is frequently mutated in BL, and this is hypothesised to reflect a need to avoid apoptosis activation whilst retaining or enhancing proliferative capability [262,263,264,265]. The gene discussed is MYC; the disease is Burkitt lymphoma.